Abstract

Long-chain polyunsaturated fatty acids (LC-PUFAs), particularly the omega-3 LC-PUFAs eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), have been associated with beneficial health effects. Consequently, sustainable sources have to be developed to meet the increasing demand for these PUFAs. Here, we demonstrate the design and construction of artificial PUFA biosynthetic gene clusters (BGCs) encoding polyketide synthase-like PUFA synthases from myxobacteria adapted for the oleaginous yeast Yarrowia lipolytica. Genomic integration and heterologous expression of unmodified or hybrid PUFA BGCs yielded different yeast strains with specific LC-PUFA production profiles at promising yield and thus valuable for the biotechnological production of distinct PUFAs. Nutrient screening revealed a strong enhancement of PUFA production, when cells were phosphate limited. This represents, to the best of our knowledge, highest concentration of DHA (16.8 %) in total fatty acids among all published PUFA-producing Y. lipolytica strains.

Highlights

  • Long-chain polyunsaturated fatty acids (LC-PUFAs), the omega-3 LC-PUFAs eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), have been associated with beneficial health effects

  • Due to its non-pathogenic nature, several processes based on Y. lipolytica were categorized as generally recognized as safe (GRAS)[5]

  • The crucial difference between oleaginous and non-oleaginous yeasts becomes evident during cultivation under nitrogen-limiting conditions[7,8]: the carbon flux in non-oleaginous yeasts is directed into synthesis of various polysaccharides, whereas in oleaginous yeasts, it is preferentially channeled towards lipid biosynthesis, leading to an accumulation of triacylglycerols within discrete intracellular lipid bodies

Read more

Summary

Introduction

Long-chain polyunsaturated fatty acids (LC-PUFAs), the omega-3 LC-PUFAs eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), have been associated with beneficial health effects. Nutrient screening revealed a strong enhancement of PUFA production, when cells were phosphate limited This represents, to the best of our knowledge, highest concentration of DHA (16.8 %) in total fatty acids among all published PUFA-producing Y. lipolytica strains. As already demonstrated in a previous study, expression of a bifunctional Δ12/ω3 desaturase from Fusarium moniliforme in Y. lipolytica yielded α-linolenic acid (18:3, n-3), a precursor of EPA and DHA, at a concentration of 28.1% of total fatty acids (TFAs)[10]. A Y. lipolytica strain that produces EPA at 56.6% of TFAs was generated by DuPont (USA)[12] These production levels were reached by overexpression of 30 copies of nine different, codon-optimized genes (20 desaturase genes, eight elongase genes, and two cholinephosphotransferase genes) combined with disruption of four genes, including a gene encoding a peroxisomal biogenesis factor and two genes involved in the lipid metabolism, in the yeast genome

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.